What We Provide

Our CRO service provides end-to-end research and development solutions tailored to the pharmaceutical industry. We specialize in preclinical and clinical research, regulatory support, formulation development, and bioanalytical services. With state-of-the-art facilities and a team of experts, we ensure high-quality, compliant, and cost-effective solutions to accelerate drug discovery and development. Our commitment to innovation and strategic collaborations enables us to deliver reliable, data-driven insights that support successful regulatory approvals and market entry. 

Our CDMO and CMO services provide end-to-end pharmaceutical solutions, from early-stage drug development to large-scale commercial production. We specialize in formulation development, process optimization, regulatory support, and high-quality manufacturing, ensuring compliance with global standards. With state-of-the-art facilities and advanced technologies, we deliver cost-effective, scalable, and efficient solutions tailored to industry needs. Our expertise in quality assurance, supply chain management, and flexible production capabilities ensures seamless product development, accelerated time-to-market, and reliable commercial supply. 

Our in-house analytical development expertise ensures precision, reliability, and regulatory compliance at every stage of pharmaceutical research and manufacturing. Equipped with cutting-edge instrumentation, our team specializes in method development, validation, and stability studies to support both small and large molecule formulations. We leverage advanced techniques such as UHPLC, NMR, XRPD, FTIR, and Mass Spectrometry to deliver accurate characterization, impurity profiling, and quality control. With a commitment to innovation and stringent regulatory standards, our analytical capabilities provide critical insights that enhance formulation development, accelerate approvals, and ensure product integrity from R&D to commercialization. 

Our formulation development strategies are designed to maximize innovation while ensuring patent non-infringement and strategic patent bypass solutions. Through cutting-edge research, we develop novel drug formulations that respect existing intellectual property while enhancing bioavailability, stability, and patient compliance. Our expertise in polymorph screening, alternative salt selection, nanoformulations, and novel drug delivery systems allows us to create differentiated products with strong market potential. By leveraging advanced analytical techniques and regulatory intelligence, we craft formulations that navigate complex patent landscapes, ensuring a competitive edge and faster market entry for our partners.